CONTRACT PHARMACEUTICAL MANUFACTURING INDUSTRY MARKET ANALYSIS BY TYPE, APPLICATION, REGIONS AND COMPANIES FORECAST

  2024-11-27 |   Pages: 200+ |   Report ID: MD-R-2024-11-27-161829 |   Pharmaceuticals

Historical data: 2018 - 2023

Forecast period: 2024 - 2031

Quantitative units: Revenue in USD million and CAGR from 2024 to 2031

Report coverage: Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Contract Pharmaceutical Manufacturing Industry Market

Image

1.1 SCOPE OF THE REPORT

1.2 MARKET SEGMENT ANALYSIS

1.3 REGULATORY SCENARIO BY REGION/COUNTRY

1.4 MARKET INVESTMENT SCENARIO STRATEGIC

1.5 MARKET ANALYSIS BY TYPE (USD MILLION)

1.6 MARKET ANALYSIS BY APPLICATION (USD MILLION)

2.1 DRIVER, RESTRAINT, CHALLENGE AND OPPORTUNITIES ANALYSIS

  2.1.1 MARKET DRIVER ANALYSIS

  2.1.2 MARKET RESTRAINT ANALYSIS

  2.1.3 MARKET OPPORTUNITY

  2.1.4 MARKET CHALLENGES

3.1 INDUSTRY TRENDS

  3.1.1 SWOT ANALYSIS

  3.1.2 PESTEL ANALYSIS

  3.1.3 PORTER’S FIVE FORCES ANALYSIS

3.2 POTENTIAL MARKET AND GROWTH POTENTIAL ANALYSIS

4.1 COVID-19 ANALYSIS

5.1 GLOBAL CONTRACT PHARMACEUTICAL MANUFACTURING INDUSTRY MARKET, SALES AREA, TYPE

5.2 MERGERS & ACQUISITIONS, PARTNERSHIPS, PRODUCT LAUNCH, AND COLLABORATION IN GLOBAL CONTRACT PHARMACEUTICAL MANUFACTURING INDUSTRY MARKET

7.1 GLOBAL CONTRACT PHARMACEUTICAL MANUFACTURING INDUSTRY MARKET SIZE AND SHARE (2018-2031) (USD MILLION)

8.1 GLOBAL CONTRACT PHARMACEUTICAL MANUFACTURING INDUSTRY MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

8.2 GLOBAL CONTRACT PHARMACEUTICAL MANUFACTURING INDUSTRY MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

9.1 GLOBAL CONTRACT PHARMACEUTICAL MANUFACTURING INDUSTRY MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

9.2 GLOBAL CONTRACT PHARMACEUTICAL MANUFACTURING INDUSTRY MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

10.1 GLOBAL CONTRACT PHARMACEUTICAL MANUFACTURING INDUSTRY MARKET SIZE AND SHARE BY REGION (2018-2023) (USD MILLION)

10.2 GLOBAL CONTRACT PHARMACEUTICAL MANUFACTURING INDUSTRY MARKET SIZE AND SHARE BY REGION (2024-2031) (USD MILLION)

11.1 NORTH AMERICA CONTRACT PHARMACEUTICAL MANUFACTURING INDUSTRY MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)

11.2 NORTH AMERICA CONTRACT PHARMACEUTICAL MANUFACTURING INDUSTRY MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

11.3 NORTH AMERICA CONTRACT PHARMACEUTICAL MANUFACTURING INDUSTRY MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

11.4 NORTH AMERICA CONTRACT PHARMACEUTICAL MANUFACTURING INDUSTRY MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

11.5 NORTH AMERICA CONTRACT PHARMACEUTICAL MANUFACTURING INDUSTRY MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

11.6 NORTH AMERICA CONTRACT PHARMACEUTICAL MANUFACTURING INDUSTRY MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

12.1 EUROPE CONTRACT PHARMACEUTICAL MANUFACTURING INDUSTRY MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)

12.2 EUROPE CONTRACT PHARMACEUTICAL MANUFACTURING INDUSTRY MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

12.3 EUROPE CONTRACT PHARMACEUTICAL MANUFACTURING INDUSTRY MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

12.4 EUROPE CONTRACT PHARMACEUTICAL MANUFACTURING INDUSTRY MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

12.5 EUROPE CONTRACT PHARMACEUTICAL MANUFACTURING INDUSTRY MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

12.6 EUROPE CONTRACT PHARMACEUTICAL MANUFACTURING INDUSTRY MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

13.1 ASIA PACIFIC CONTRACT PHARMACEUTICAL MANUFACTURING INDUSTRY MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)

13.2 ASIA PACIFIC CONTRACT PHARMACEUTICAL MANUFACTURING INDUSTRY MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

13.3 ASIA PACIFIC CONTRACT PHARMACEUTICAL MANUFACTURING INDUSTRY MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

13.4 ASIA PACIFIC CONTRACT PHARMACEUTICAL MANUFACTURING INDUSTRY MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

13.5 ASIA PACIFIC CONTRACT PHARMACEUTICAL MANUFACTURING INDUSTRY MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

13.6 ASIA PACIFIC CONTRACT PHARMACEUTICAL MANUFACTURING INDUSTRY MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

14.1 LATIN AMERICA CONTRACT PHARMACEUTICAL MANUFACTURING INDUSTRY MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)/p>

14.2 LATIN AMERICA CONTRACT PHARMACEUTICAL MANUFACTURING INDUSTRY MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

14.3 LATIN AMERICA CONTRACT PHARMACEUTICAL MANUFACTURING INDUSTRY MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

14.4 LATIN AMERICA CONTRACT PHARMACEUTICAL MANUFACTURING INDUSTRY MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

14.5 LATIN AMERICA CONTRACT PHARMACEUTICAL MANUFACTURING INDUSTRY MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

14.6 LATIN AMERICA CONTRACT PHARMACEUTICAL MANUFACTURING INDUSTRY MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

15.1 MIDDLE EAST & AFRICA CONTRACT PHARMACEUTICAL MANUFACTURING INDUSTRY MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)

15.2 MIDDLE EAST & AFRICA CONTRACT PHARMACEUTICAL MANUFACTURING INDUSTRY MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

15.3 MIDDLE EAST & AFRICA CONTRACT PHARMACEUTICAL MANUFACTURING INDUSTRY MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

15.4 MIDDLE EAST & AFRICA CONTRACT PHARMACEUTICAL MANUFACTURING INDUSTRY MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

15.5 MIDDLE EAST & AFRICA CONTRACT PHARMACEUTICAL MANUFACTURING INDUSTRY MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

15.6 MIDDLE EAST & AFRICA CONTRACT PHARMACEUTICAL MANUFACTURING INDUSTRY MARKET SIZE AND SHARE BY APPLICATION (2024-2031)< (USD MILLION)/p>

16.1 Jubilant

  16.1.1 COMPANY DETAILS

  16.1.2 FINANCIALS (USD MILLION)

  16.1.3 PRODUCT SUMMARY

  16.1.4 RECENT DEVELOPMENTS

16.2 Nipro Corp

16.3 DPx

16.4 Catalent

16.5 Lonza

16.6 Vetter

16.7 Piramal Healthcare

16.8 Recipharm

16.9 Dishman

16.10 NextPharma

16.11 Sopharma

16.12 DPT Laboratories

16.13 Boehringer Ingelheim

16.14 Fareva Holding

16.15 Aesica

16.16 Aenova

16.17 AbbVie

16.18 Famar

18.1 METHODOLOGY

18.2 RESEARCH DATA SOURCE

  18.2.1 SECONDARY DATA

  18.2.2 KEY DATA FROM SECONDARY

  18.2.3 PRIMARY DATA

  18.2.4 KEY DATA FROM PRIMARY

  18.2.5 INDUSTRY INSIGHT FROM PROFESSIONAL LEADERS

  18.2.6 MARKET ESTIMATION

  18.2.7 MARKET ESTIMATION: TOP-DOWN AND BOTTOM-UP APPROACH

  18.2.8 LEGAL DISCLAIMER

Market Segments

Market by Type :

Active Pharmaceutical Ingredients (API)
Finished Dosage Formulations (FDF)

Market by Application :

Development
Manufacturing
Testing

Companies

Jubilant
Nipro Corp
DPx
Catalent
Lonza
Vetter
Piramal Healthcare
Recipharm
Dishman
NextPharma
Sopharma
DPT Laboratories
Boehringer Ingelheim
Fareva Holding
Aesica
Aenova
AbbVie
Famar

BROWSE INDUSTRY

  1. Consumer Goods
  2. Healthcare
  3. Food & Beverage
  4. Heavy Industry
  5. Service Industries
  6. FMCG
  7. Life Sciences
  8. Technology & Media
  9. Machinery & Equipment

    WHY CHOOSE US

  •   PROACTIVE
  • We manage our resources 24/7 to identify issues and address them before they become problems.

  •   QUALITY & RELIABILITY
  • We are committed to providing reliable and highly accurate data with an excellent quality control system.

  •   GLOBAL OUTREACH
  • 6 Major regions and 40+ countries level analysis accomplished.

  •   COMPETITIVE PRICING
  • Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery.